About US
Contact us
-
Biogen inks $22M charity kickbacks deal with feds, but argues its conduct was appropriateOver the last few years, the federal government has inked charity kickback settlements with a who’s who of pharma companies. With a new Department of Justice settlement unveiled Thursday, Biogen is j2020/12/21
-
Singapore approves Pfizer and BioNTech’s Covid-19 vaccineSingapore has approved the Covid-19 vaccine by Pfizer and its German partner BioNTech, as well as expects delivery of the first shots by December-end. Singapore is the first Asian country to approve2020/12/18
-
FDA finds Moderna’s Covid-19 vaccine to have no specific safety concernsThe US Food and Drug Administration (FDA) has stated in its briefing document that Moderna’s experimental Covid-19 vaccine, mRNA-1273, is 94.1% effective in preventing symptomatic Covid-19. The U2020/12/18
-
Japan's Kobayashi Kako admits manufacturing mix-up led to patient's deathA "grave" manufacturing error in Japan tainted antifungal tablets with high doses of a sleep medication, leading to the death of one woman in her 70s and side effects in hundreds more people. Kobayas2020/12/17
-
Sanofi promised pandemic hazard pay to vaccine plant workers, then offered 3 days off instead, lawsuit saysAs the pandemic heated up this spring, Sanofi scrambled to make sure its plants would continue to turn out the drugs and vaccines patients needed—and it offered certain workers hazard pay as part of2020/12/17
-
Communication is the strong link in a supply-chain crisisEditorial Note: This article is custom content created in collaboration with AmerisourceBergen. As the COVID-19 crisis began to take hold in the U.S. earlier this year, healthcare systems scrambled t2020/12/16
-
Ex-FDA chief Gottlieb pushes for antibody manufacturing scale up as 2021 pandemic 'insurance policy'Even as COVID-19 vaccines start to creep across the regulatory finish line, supplies willbe limited for months at least. Meanwhile, antibody drugs, hailed as a crucial stopgap treatment since the pan2020/12/16
-
Lilly eyes up to $2B in COVID-19 sales by year-end—plus revenue boosts in cancer, diabetes and moreEli Lilly has the rare distinction of scoring not just one, but two, FDA emergency use authorizations for COVID-19 therapeutics—and now we know what that distinction will deliver to its top and botto2020/12/15
-
Pfizer/BioNTech weren't alone: Moderna COVID-19 vaccine data targeted in EMA cyberattackLooks like Pfizer and BioNTech’s COVID-19 vaccine was not the sole target of a recent cyberattack at the European Medicines Agency. ModernasaidMonday that documents from itspre-submission discussions2020/12/14
-
Does AstraZeneca get enough out of its $39B deal for Alexion—and vice versa?Industry watchers have been searching their crystal balls, trying to read Alexion's future. Theyfloated several potential buyers—including Pfizer, Sanofi, Biogen and Amgen—but not AstraZeneca. So whe2020/12/14